Akebia Therapeutics (AKBA) Current Taxes (2017 - 2018)
Akebia Therapeutics' (AKBA) quarterly Current Taxes came in at $987000.0 in Q1 2018, little changed on a QoQ basis from $987000.0 in Q4 2017.
Akebia Therapeutics (AKBA) Current Taxes (2017 - 2018) Analysis & Trends
Akebia Therapeutics (AKBA) has 2 years of Current Taxes data on file, last reported at $987000.0 in Q1 2018.
- On a quarterly basis, Current Taxes changed N/A year-over-year to $987000.0 in Q1 2018; TTM through Mar 2018 was $987000.0, a N/A change from a year earlier, with the FY2017 full-year figure at $987000.0, changed N/A from the prior year.
- Current Taxes for Q1 2018 stood at $987000.0, roughly flat from $987000.0 in the prior quarter.
- Over the last five years, Current Taxes for AKBA reached as high as $987000.0 in Q4 2017 and fell as low as $987000.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 355.15 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 211.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 624.14 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 640.78 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Akebia Therapeutics | 325.80 Mn | 163.20 Mn | 41.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 987,000.00 |
| Dec 31, 2017 | 987,000.00 |